Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 25390 | 235 | 35.3 | 89% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CCNG2 | Author keyword | 18 | 89% | 3% | 8 |
| 2 | CYCLIN G2 | Author keyword | 9 | 67% | 3% | 8 |
| 3 | CYCLIN G | Author keyword | 8 | 62% | 3% | 8 |
| 4 | CYCLIN B1 | Author keyword | 6 | 14% | 18% | 42 |
| 5 | CYCLIN G1 | Author keyword | 5 | 37% | 5% | 11 |
| 6 | PEOPLES HOSP TAIZHOU | Address | 4 | 67% | 2% | 4 |
| 7 | TAIZHOU MED | Address | 2 | 40% | 2% | 4 |
| 8 | CYCLIN L2 | Author keyword | 1 | 50% | 1% | 2 |
| 9 | HIP2 | Author keyword | 1 | 50% | 1% | 2 |
| 10 | PROTEIN PATHWAY ARRAY | Author keyword | 1 | 50% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CCNG2 | 18 | 89% | 3% | 8 | Search CCNG2 | Search CCNG2 |
| 2 | CYCLIN G2 | 9 | 67% | 3% | 8 | Search CYCLIN+G2 | Search CYCLIN+G2 |
| 3 | CYCLIN G | 8 | 62% | 3% | 8 | Search CYCLIN+G | Search CYCLIN+G |
| 4 | CYCLIN B1 | 6 | 14% | 18% | 42 | Search CYCLIN+B1 | Search CYCLIN+B1 |
| 5 | CYCLIN G1 | 5 | 37% | 5% | 11 | Search CYCLIN+G1 | Search CYCLIN+G1 |
| 6 | CYCLIN L2 | 1 | 50% | 1% | 2 | Search CYCLIN+L2 | Search CYCLIN+L2 |
| 7 | HIP2 | 1 | 50% | 1% | 2 | Search HIP2 | Search HIP2 |
| 8 | PROTEIN PATHWAY ARRAY | 1 | 50% | 1% | 2 | Search PROTEIN+PATHWAY+ARRAY | Search PROTEIN+PATHWAY+ARRAY |
| 9 | STICKY SIRNA | 1 | 40% | 1% | 2 | Search STICKY+SIRNA | Search STICKY+SIRNA |
| 10 | ANTI CANCER VACCINATION | 1 | 50% | 0% | 1 | Search ANTI+CANCER+VACCINATION | Search ANTI+CANCER+VACCINATION |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | B1 OVEREXPRESSION | 6 | 80% | 2% | 4 |
| 2 | G1 CONSTRUCT | 1 | 100% | 1% | 2 |
| 3 | G1 GENE | 1 | 100% | 1% | 2 |
| 4 | CLINICAL IMPLICATION | 1 | 16% | 2% | 4 |
| 5 | CYCLIN B1 OVEREXPRESSION | 1 | 50% | 0% | 1 |
| 6 | E2 25K | 1 | 50% | 0% | 1 |
| 7 | INTERACTING PROTEIN HPIP | 1 | 50% | 0% | 1 |
| 8 | DEPENDENT KINASE ACTIVITIES | 0 | 33% | 0% | 1 |
| 9 | G2 M MODULATORS | 0 | 33% | 0% | 1 |
| 10 | HISTOLOGICAL DIFFERENTIATION | 0 | 33% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer | 2006 | 40 | 17 | 24% |
| Repopulation of the liver after dipin-induced damage | 1997 | 0 | 8 | 38% |
| Cyclin G2 is a centrosome-associated nucleocytoplasmic shuttling protein that influences microtubule stability and induces a p53-dependent cell cycle arrest | 2006 | 29 | 98 | 10% |
| Role of Cyclin B1 Levels in DNA Damage and DNA Damage-Induced Senescence | 2013 | 2 | 182 | 8% |
| Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe | 2002 | 165 | 57 | 2% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PEOPLES HOSP TAIZHOU | 4 | 67% | 1.7% | 4 |
| 2 | TAIZHOU MED | 2 | 40% | 1.7% | 4 |
| 3 | JIANGSU PROV INFORMAT MOL DRUG TARGET | 1 | 40% | 0.9% | 2 |
| 4 | CHEMORADIOTHER Y | 1 | 13% | 2.1% | 5 |
| 5 | ADV TRAINING PROGRAM | 1 | 50% | 0.4% | 1 |
| 6 | ALLIANCE CELLULAR SIGNALING PHARMACOL | 1 | 50% | 0.4% | 1 |
| 7 | CELL PREPARAT ANAL | 1 | 50% | 0.4% | 1 |
| 8 | ENDOCRINOLPALDAL GU | 1 | 50% | 0.4% | 1 |
| 9 | JODHPUR DENT HOSP | 1 | 50% | 0.4% | 1 |
| 10 | MED GENOM CELL BIOLMINIST PUBL H | 1 | 50% | 0.4% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000171097 | CYCLIN D1//CYCLIN E//CCND1 |
| 2 | 0.0000159143 | CAK//CDC2//CYCLIN A1 |
| 3 | 0.0000088017 | REVERSINE//MITOTIC CATASTROPHE//WP 631 |
| 4 | 0.0000076470 | NF Y//NF YB//CCAAT BOX |
| 5 | 0.0000069070 | CDK2AP1//DOC 1//P12CDK2 AP1 |
| 6 | 0.0000065131 | CIP2A//PROTEIN PHOSPHATASE 2A//PP2A |
| 7 | 0.0000061380 | FLAVOPIRIDOL//CELL CYCLE REGULAT GRP//ROSCOVITINE |
| 8 | 0.0000057513 | GENE THER Y S//PATHOTROPIC TARGETING//RETROVIRAL ENTRY |
| 9 | 0.0000057455 | POLO LIKE KINASE 1//POLO BOX DOMAIN//PLK1 |
| 10 | 0.0000056647 | NECDIN//REGULAT MACROMOL FUNCT//REGULAT NEURONAL DEV |